Assisting Smokers to Switch to an e-Cigarette by Accelerating Learning of Adaptive Habits Using D-cycloserine

Phase 2 Completed 25 enrolled Rose Research Center, LLC Foundation for a Smoke Free World INC · collab

NaSingle-groupOpen-labelTreatment

Summary

This study will evaluate the effects of a reward devaluation strategy, which has been researched in the past, combined/augmented with the medication d-cycloserine in assisting smokers to switch from combustible cigarette (CC) to Juul.

Timeline

Start: 2023-10-20
Primary completion: 2025-10-13
Completion: 2026-01-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Cycloserine	Small molecule	100 mg	Oral

Indications

No indication recorded.